Dr. Jilani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8881 N Main St
Dayton, OH 45415Phone+1 937-293-1622Fax+1 937-245-6308
Education & Training
- NYU Grossman Long Island School of MedicineFellowship, Hematology and Medical Oncology, 1991 - 1994
- Flushing Hospital Medical CenterResidency, Internal Medicine, 1987 - 1990
- Peoples University of Medical and Health Sciences - NawabshahClass of 1980
Certifications & Licensure
- OH State Medical License 1995 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACP) American College of Physicians, 2004
Publications & Presentations
PubMed
- 95 citationsPhase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study...Domingo G. Perez, Vera J. Suman, Tom R. Fitch, Thomas Amatruda, Roscoe F. Morton
Cancer. 2009-01-01 - A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive...Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang
Research Square. 2024-04-29 - A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive...Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang
Breast Cancer Research and Treatment. 2024-09-01
Professional Memberships
- Fellow
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: